Merck's Keytruda Pulled for SCLC as FDA Re-Evaluates Past Accelerated Approvals | BioSpace
Could a popular COVID-19 antiviral supercharge the pandemic? | Science | AAAS
FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back | Fierce Biotech
Merck Sells Covid Pill for 40 Times What It Costs to Make
Merck-Launches-Alzheimers-Trial
Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccine | Fierce Pharma
Merck & Co. - Wikipedia
Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators' review time only one benefit | Fierce Pharma
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck leads rivals in novel drug approvals | Evaluate
New COVID-19 pills may keep recently diagnosed patients out of hospital, company says - ABC News
Gardasil pulls in $1.5bn, driving vaccines for Merck - BioProcess InsiderBioProcess International
Merck Pulls Ahead Renewable Energy Goal by 15 Years, Aims for Carbon Neutrality by 2025 - ESG Today
Merck & Co - Drug Company History, Products & Lawsuits
Group sues to have hair-loss drug Propecia pulled from market | Reuters
Merck Closes Deal for Acceleron Pharma, Biggest Biotech Merger of the Year | Barron's
Vioxx Drug Pulled from Shelves : NPR
Merck Explores Purchase of Biotech Seagen - WSJ
HCPC Announces 2016 Compliance Packages of the Year | Healthcare Packaging
